Clinical Trial Update: THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating various strategies of patient-controlled analgesia for pain management in sickle cell disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Carelon Research | Conditions: Sickle Cell Disease | Phase 3 | Status: TERMINATED